Plus Therapeutics Inc (PSTV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,241 | -10,887 | -12,634 | -22,686 | -22,046 |
| Depreciation Amortization | 950 | 1,446 | 2,582 | 2,858 | 2,136 |
| Accounts receivable | 1,169 | -1,203 | -173 | 1,129 | -179 |
| Other Working Capital | 119 | -938 | -1,032 | -1,037 | -772 |
| Other Operating Activity | -2,431 | 5,676 | -718 | 1,608 | 1,328 |
| Operating Cash Flow | $-8,434 | $-5,906 | $-11,975 | $-18,128 | $-19,533 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -93 | -67 | -133 | -182 | 64 |
| Net Acquisitions | N/A | 5,637 | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | N/A | N/A | -1,201 | N/A |
| Other Investing Activity | -400 | 0 | 0 | -1,201 | 0 |
| Investing Cash Flow | $-493 | $5,570 | $-133 | $-1,383 | $64 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,424 | -3,823 | N/A | -4,720 | 0 |
| Common Stock Issued | 5,105 | 16,454 | N/A | 23,613 | 21,467 |
| Other Financing Activity | 0 | 0 | 7,168 | -2,078 | -3,858 |
| Financing Cash Flow | $-319 | $12,631 | $7,168 | $16,815 | $17,609 |
| Exchange Rate Effect | N/A | -4 | 16 | 11 | 82 |
| Beginning Cash Position | 17,592 | 5,301 | 10,225 | 12,910 | 14,338 |
| End Cash Position | 8,346 | 17,592 | 5,301 | 10,225 | 12,560 |
| Net Cash Flow | $-9,246 | $12,291 | $-4,924 | $-2,685 | $-1,778 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,434 | -5,906 | -11,975 | -18,128 | -19,533 |
| Capital Expenditure | -93 | -67 | -133 | -295 | -67 |
| Free Cash Flow | -8,527 | -5,973 | -12,108 | -18,423 | -19,600 |